S.B. No. 1633
AN ACT
relating to the supervision of pharmacist-interns, pharmacy
technicians, and pharmacy technician trainees by a pharmacist and
the provision of pharmacy services through a telepharmacy system;
establishing a remote dispensing site license.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Section 551.003, Occupations Code, is amended by
adding Subdivision (15-a) to read as follows:
(15-a) "Direct supervision" means supervision by a
pharmacist who directs the activities of a pharmacist-intern,
pharmacy technician, or pharmacy technician trainee to a sufficient
degree to ensure the activities are performed accurately, safely,
and without risk of harm to patients, as specified by board rule.
SECTION 2. Section 554.053(a), Occupations Code, is amended
to read as follows:
(a) The board shall establish rules for the use and the
duties of a pharmacy technician and pharmacy technician trainee
employed by [in] a pharmacy licensed by the board. A pharmacy
technician and pharmacy technician trainee shall be responsible to
and must be directly supervised by a pharmacist.
SECTION 3. Section 562.110, Occupations Code, is amended by
amending Subsections (a), (b), (d), (e), and (f) and adding
Subsections (g), (h), (i), (j), and (k) to read as follows:
(a) In this section:
(1) "Provider pharmacy" means a Class A pharmacy that
provides pharmacy services through a telepharmacy system at a
remote dispensing site.
(2) "Remote dispensing site" means a location licensed
as a telepharmacy that is authorized by a provider pharmacy through
a telepharmacy system to store and dispense prescription drugs and
devices, including dangerous drugs and controlled substances.
(3) "Telepharmacy[, "telepharmacy] system" means a
system that monitors the dispensing of prescription drugs and
provides for related drug use review and patient counseling
services by an electronic method, including the use of the
following types of technology:
(A) [(1)] audio and video;
(B) [(2)] still image capture; and
(C) [(3)] store and forward.
(b) A Class A or Class C pharmacy located in this state may
provide pharmacy services, including the dispensing of drugs,
through a telepharmacy system at locations separate from [in a
facility that is not at the same location as] the Class A or Class C
pharmacy.
(d) A telepharmacy system may be located only at:
(1) a health care facility in this state that is
regulated by this state or the United States; or
(2) a remote dispensing site.
(e) The board shall adopt rules regarding the use of a
telepharmacy system under this section, including:
(1) the types of health care facilities at which a
telepharmacy system may be located under Subsection (d)(1), which
must include the following facilities:
(A) a clinic designated as a rural health clinic
regulated under 42 U.S.C. Section 1395x(aa)[, as amended]; and
(B) a health center as defined by 42 U.S.C.
Section 254b[, as amended];
(2) the locations eligible to be licensed as remote
dispensing sites, which must include locations in medically
underserved areas, areas with a medically underserved population,
and health professional shortage areas determined by the United
States Department of Health and Human Services;
(3) licensing and operating requirements for remote
dispensing sites, including:
(A) a requirement that a remote dispensing site
license identify the provider pharmacy that will provide pharmacy
services at the remote dispensing site;
(B) a requirement that a provider pharmacy be
allowed to provide pharmacy services at not more than two remote
dispensing sites;
(C) a requirement that a pharmacist employed by a
provider pharmacy make at least monthly on-site visits to a remote
dispensing site or more frequent visits if specified by board rule;
(D) a requirement that each month the perpetual
inventory of controlled substances at the remote dispensing site be
reconciled to the on-hand count of those controlled substances at
the site by a pharmacist employed by the provider pharmacy;
(E) a requirement that a pharmacist employed by a
provider pharmacy be physically present at a remote dispensing site
when the pharmacist is providing services requiring the physical
presence of the pharmacist, including immunizations;
(F) a requirement that a remote dispensing site
be staffed by an on-site pharmacy technician who is under the
continuous supervision of a pharmacist employed by the provider
pharmacy;
(G) a requirement that all pharmacy technicians
at a remote dispensing site be counted for the purpose of
establishing the pharmacist-pharmacy technician ratio of the
provider pharmacy, which, notwithstanding Section 568.006, may not
exceed three pharmacy technicians for each pharmacist providing
supervision;
(H) a requirement that, before working at a
remote dispensing site, a pharmacy technician must:
(i) have worked at least one year at a
retail pharmacy during the three years preceding the date the
pharmacy technician begins working at the remote dispensing site;
and
(ii) have completed a board-approved
training program on the proper use of a telepharmacy system;
(I) a requirement that pharmacy technicians at a
remote dispensing site may not perform extemporaneous sterile or
nonsterile compounding but may prepare commercially available
medications for dispensing, including the reconstitution of orally
administered powder antibiotics; and
(J) any additional training or practice
experience requirements for pharmacy technicians at a remote
dispensing site;
(4) the areas that qualify under Subsection (f);
(5) [(3)] recordkeeping requirements; and
(6) [(4)] security requirements.
(f) A telepharmacy system located at a health care facility
under Subsection (d)(1) may not be located in a community in which a
Class A or Class C pharmacy is located as determined by board rule.
If a Class A or Class C pharmacy is established in a community in
which a telepharmacy system has been located under this section,
the telepharmacy system may continue to operate in that community.
(g) A telepharmacy system located at a remote dispensing
site under Subsection (d)(2) may not dispense a controlled
substance listed in Schedule II as established by the commissioner
of state health services under Chapter 481, Health and Safety Code.
(h) Except as provided by Subsection (j), a telepharmacy
system located at a remote dispensing site under Subsection (d)(2)
may not be located within 25 miles by road of a Class A pharmacy.
(i) Except as provided by Subsection (j), if a Class A
pharmacy is established within 25 miles by road of a remote
dispensing site that is currently operating, the remote dispensing
site may continue to operate at that location.
(j) A telepharmacy system located at a remote dispensing
site under Subsection (d)(2) in a county with a population of at
least 13,000 but not more than 14,000 may not be located within 22
miles by road of a Class A pharmacy. If a Class A pharmacy is
established within 22 miles by road of a remote dispensing site
described by this subsection that is currently operating, the
remote dispensing site may continue to operate at that location.
(k) The board by rule shall require and develop a process
for a remote dispensing site to apply for classification as a Class
A pharmacy if the average number of prescriptions dispensed each
day the remote dispensing site is open for business is more than
125, as calculated each calendar year.
SECTION 4. The Texas State Board of Pharmacy shall adopt
rules under Section 562.110, Occupations Code, as amended by this
Act, not later than January 1, 2018.
SECTION 5. This Act takes effect September 1, 2017.
______________________________ ______________________________
President of the Senate Speaker of the House
I hereby certify that S.B. No. 1633 passed the Senate on
April 27, 2017, by the following vote: Yeas 31, Nays 0;
May 25, 2017, Senate refused to concur in House amendments and
requested appointment of Conference Committee; May 26, 2017, House
granted request of the Senate; May 28, 2017, Senate adopted
Conference Committee Report by the following vote: Yeas 29,
Nays 1.
______________________________
Secretary of the Senate
I hereby certify that S.B. No. 1633 passed the House, with
amendments, on May 24, 2017, by the following vote: Yeas 132,
Nays 13, three present not voting; May 26, 2017, House granted
request of the Senate for appointment of Conference Committee;
May 28, 2017, House adopted Conference Committee Report by the
following vote: Yeas 138, Nays 6, three present not voting.
______________________________
Chief Clerk of the House
Approved:
______________________________
Date
______________________________
Governor